Jane Beith, MBBS, PhD

home / authors / jane-beith-mbbs-phd

Articles

Site Logo

Fear of Cancer Recurrence: A Practical Guide for Clinicians

Phyllis Butow, MClinPsych, MPH, PhD;Louise Sharpe, PhD;Belinda Thewes, PhD;Jane Turner, PhD;Jemma Gilchrist, MClinPsych;Jane Beith, MBBS, PhD
January 15th 2018

With increasing cancer survival, fear of cancer recurrence (FCR) is becoming a prominent clinical issue. FCR is prevalent, distressing, and long-lasting, and can negatively impact patients’ quality of life, use of health services, and adherence to follow-up recommendations. Novel targeted therapies may increase risk of FCR because of longer treatment duration and follow-up, increased prognostic precision, and omission of treatment based on genomic status.

Latest Updated Articles

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Skin Lesions in Patient With Metastatic Breast Cancer
Published: December 3rd 2017 | Updated: November 5th 2024
Skin Lesions in Patient With Metastatic Breast Cancer
4 KOLs are featured in this series.
Published: November 1st 2024 | Updated: November 5th 2024
Management of Bispecifc AE’s in the Community Setting of Multiple Myeloma Patients
Metastatic Renal Cell Carcinoma With Sarcomatoid Features
Published: April 15th 2022 | Updated: November 5th 2024
Metastatic Renal Cell Carcinoma With Sarcomatoid Features